Conforma Therapeutics Corporation

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8093229 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitorsMay 22, 09Jan 10, 12[A61K, C07F, C07D, A61P]
7544672 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitorsMar 29, 06Jun 09, 09[A61K, C07F, C07D]
7241890 Purine analogs having HSP90-inhibiting activityOct 30, 02Jul 10, 07[C07D]
7148228 Pyrazolopyrimidines and related analogs as HSP90-inhibitorsSep 20, 04Dec 12, 06[C07D]
7138401 2-aminopurine analogs having HSP90-inhibiting activitySep 20, 04Nov 21, 06[C07D]
7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitorsSep 20, 04Nov 21, 06[C07D]
7129244 Triazolopyrimidines and related analogs as HSP90-inhibitorsSep 20, 04Oct 31, 06[C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0063,020 ORAL PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAMEAbandonedSep 04, 09Mar 11, 10[A61K, A61P]
2009/0238,880 PHOSPHOLIPID-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR PRODUCING AND USING SAMEAbandonedFeb 12, 09Sep 24, 09[A61K, A61P]
7579462 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycinsExpiredSep 18, 02Aug 25, 09[C07D]
7553979 HSP90-inhibiting zearalanol compounds and methods of producing and using sameExpiredNov 08, 02Jun 30, 09[A01N, C07D]
2008/0318,338 Assays and Implements for Determining and Modulating HSP90 Binding ActivityAbandonedApr 15, 08Dec 25, 08[G01N, C07K]
7465718 Ansamycins having improved pharmacological and biological propertiesExpiredFeb 10, 03Dec 16, 08[C07D]
2008/0280,878 Methods and Compositions for Treating Chronic Lymphocytic LeukemiaAbandonedNov 02, 05Nov 13, 08[A61K, A61P]
2008/0125,446 Purine analogs having HSP90-inhibiting activityAbandonedJul 02, 07May 29, 08[A61K, C07D, C12N, C07K]
2008/0051,462 Methods for treating genetically-defined proliferative disorders with HSP90 inhibitorsAbandonedJul 17, 07Feb 28, 08[A61K, C12Q, A61P]
2007/0253,896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-InhibitorsAbandonedFeb 05, 07Nov 01, 07[A61K, C07D, A61P]
2007/0185,064 2-Aminopurine Analogs Having HSP90-Inhibiting ActivityAbandonedSep 12, 06Aug 09, 07[A61K, C07F, C07D]
2007/0173,483 Pyrrolopyrimidines and Related Analogs as HSP90-InhibitorsAbandonedSep 12, 06Jul 26, 07[A61K, C07F, C07D]
2007/0129,334 Orally Active Purine-Based Inhibitors of Heat Shock Protein 90AbandonedDec 18, 06Jun 07, 07[A61K, C07D]
2007/0129,342 Compositions Containing AnsamycinAbandonedNov 30, 06Jun 07, 07[A61K]
2007/0111,996 Pyrazolopyrimidines and related analogs as HSP90-inhibitorsAbandonedSep 29, 06May 17, 07[A61K]
2007/0111,997 Triazolopyrimidines and related analogs as HSP90-inhibitorsAbandonedSep 29, 06May 17, 07[A61K]
2007/0105,874 Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 InhibitorsAbandonedSep 25, 06May 10, 07[A61K]
2006/0251,574 Cytotoxins and diagnostic imaging agents comprising hsp90 ligandsAbandonedJun 12, 03Nov 09, 06[A61K, C07F]
2006/0228,405 Phospholipid-based pharmaceutical formulations and methods for producing and using sameAbandonedApr 07, 06Oct 12, 06[A61K]
2006/0148,776 Drug formulations having long and medium chain triglyceridesAbandonedOct 04, 03Jul 06, 06[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.